The various constituents of the Antiviral Regimen do have varied anticancer effects directly on malignant cells to help contain them. This is not the most potent way to ensure eradication of tumors, by any means, and that is more of a problem here, because malignancy can become more of a threat than the original chronic virus. So letting significant numbers of malignant cells survive with a cessation of treatment can allow a reoccurrence of tumors, and then a life-threatening situation. But this is why using the multiple-source Antiviral Regimen along with ivermectin and hydroxychloroquine would be advantageous.
Please login or Register to submit your answer